Dr. Reddy’s gets FDA approval, launches generic version of Suboxone
Dr. Reddy’s Laboratories announced today that it has received final approval from the U.S. Food and Drug Administration (USFDA) and is launching buprenorphine and naloxone sublingual film, 2 mg/0.